Efficacy of a High-Intensity Interval Exercise Program Versus a Dual-Task Training Program in People With Alzheimer's: A Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Alzheimer's disease (AD) is a the most common type of dementia. It is a progressive disease that affects different areas of human behavior at the cognitive, social, physical and metabolic levels. The benefits of a High-Intensity Interval Exercise Program (HIIT) has been proven not only in healthy older adults, but also in different pathologies, such as cerebrovascular and cardiometabolic diseases. However, there are no studies to date that examine the impact of HIIT in people with AD. The aim of this study was to ascertain the effectiveness of a HIIT program versus a cognitive and motor dual task balance program on parameters related to functional capacity and cognitive function in people with AD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 90
Healthy Volunteers: f
View:

• Aged between 60 -90 years

• Diagnosed with mild or moderate AD according to the Clinical Dementia Rating (CDR1).

• Ability to follow the instructions of the training program.

• Ability to get up from a chair alone.

• Independent ambulation.

• Providing signed informed consent.

Locations
Other Locations
Spain
Faculty of Physiotherapy, University of Valencia
RECRUITING
Valencia
Contact Information
Primary
Marta Inglés, PhD
marta.ingles@uv.es
(+34) 96 398 38 55
Time Frame
Start Date: 2022-12-20
Estimated Completion Date: 2026-01
Participants
Target number of participants: 66
Treatments
Experimental: HIIT intervention
Patients in this group (n=22) will undergo a HIIT training protocol for 12 weeks
Experimental: Dual task intervention (DT)
Patients in this group (n=22) will undergo a DT training protocol for 12 weeks
No_intervention: Control group (CG)
Patients in this group (n=22) will not perform any exercise during the intervention period (12 weeks)
Related Therapeutic Areas
Sponsors
Leads: University of Valencia

This content was sourced from clinicaltrials.gov